HIV & AIDS control programme

HIV & AIDS control programme

The HIV & AIDS control program is a national health program in India aimed at preventing and controlling the spread of HIV and AIDS. The program was launched in 1992, and it aims to reduce the transmission of HIV and to provide care and support to people living with HIV.

The objectives of the HIV & AIDS control program in India are:

1. Prevention of new HIV infections through awareness-raising, behavior change communication, and condom promotion.
2. Providing counseling, testing, and treatment services for people living with HIV.
3. Reducing HIV-related stigma and discrimination.
4. Ensuring the availability of antiretroviral therapy (ART) for all those who need it.
5. Building the capacity of health systems to provide comprehensive HIV care.

The program is implemented through a multi-sectoral approach involving the government, civil society organizations, and community-based organizations. The program is guided by the National AIDS Control Organization (NACO) and is supported by international organizations such as the United Nations Development Programme (UNDP), the World Health Organization (WHO), and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

The HIV & AIDS control program in India has achieved some notable successes. The prevalence of HIV in India has declined from 0.41% in 2001 to 0.22% in 2017. The program has also increased access to ART for people living with HIV. In 2019, 1.5 million people in India were receiving ART, up from 120,000 in 2005. The program has also contributed to reducing stigma and discrimination against people living with HIV.

However, challenges remain in the fight against HIV and AIDS in India. There is still a significant burden of HIV in certain populations, such as men who have sex with men, transgender people, and people who inject drugs. Access to HIV testing and treatment services is not equitable across the country, and there are issues around the quality of care provided to people living with HIV. The HIV & AIDS control program in India must continue to address these challenges to achieve its goals of reducing the transmission of HIV and providing care and support to people living with HIV.

Final Year B Pharm Notes, Syllabus, Books, PDF Subjectwise/Topicwise

Final Year B Pharm Sem VII	BP701T Instrumental Methods of Analysis Theory
BP702T Industrial Pharmacy Theory	BP703T Pharmacy Practice Theory
BP704T Novel Drug Delivery System Theory	BP705 P Instrumental Methods of Analysis Practical
Final Year B Pharm Sem VII	BP801T Biostatistics and Research Methodology Theory
BP802T Social and Preventive Pharmacy Theory	BP803ET Pharmaceutical Marketing Theory
BP804ET Pharmaceutical Regulatory Science Theory	BP805ET Pharmacovigilance Theory
BP806ET Quality Control and Standardization of Herbals Theory	BP807ET Computer-Aided Drug Design Theory
BP808ET Cell and Molecular Biology Theory	BP809ET Cosmetic Science Theory
BP810ET Experimental Pharmacology Theory	BP811ET Advanced Instrumentation Techniques Theory
BP812ET Dietary supplements and Nutraceuticals	Pharmaceutical Product Development

Suggested readings:

• HIV AIDS, Sexually Transmitted disease Social Pharmacy Notes
• A clinical trial of mRNA HIV vaccine development programme: First-in-Africa by IAVI, Moderna
• National Health programs in India
• 802T Social and Preventive Pharmacy Syllabus, Notes, PDF, Books
• <strong>National health programs, its objectives, functioning and outcome</strong>